Literature DB >> 8454341

Isolation and biochemical characterization of the iC3b receptor of Candida albicans.

S Alaei1, C Larcher, C Ebenbichler, W M Prodinger, J Janatova, M P Dierich.   

Abstract

In an effort to identify the protein structure on Candida albicans, pseudohyphal forms which had been shown earlier to bind human iC3b, a protein of about 42 kDa (p42), were obtained from lysates of pseudohyphal forms by absorption with C3(H2O)-Sepharose. An antiserum raised in rabbits against this protein effectively inhibited adherence of sheep erythrocytes carrying iC3b (EAC3bi) to pseudohyphal forms. p42 cross-reacted with OKM-1, a monoclonal antibody directed against the human complement receptor type 3 (CR3, CD11b). This protein, p42, was designated p42-CR3. The antiserum against p42-CR3 was used for further purification of lysates by affinity chromatography. Three proteins of 66, 55, and 42 kDa were isolated. All were recognized by OKM-1 in immunoblots (p66-, p55-, and p42-CR3). The different proteins were separated and treated with neuraminidase and endoglycosidase F. Almost complete deglycosylation of the p66-CR3 protein was obtained after treatment with neuraminidase, indicating a high degree of glycosylation. Neuraminidase also had an effect on p55-CR3, but not on p42-CR3. Endoglycosidase F did not alter any of the three proteins. In ligand blots, p42-CR3 bound C3(H2O), C3b, and iC3b but not C3d; p55-CR3 clearly reacted with C3(H2O) and weakly reacted with C3b and iC3b. p66-CR3 never showed reactivity. It is suggested that p55 and p66 represent glycosylated forms of p42-CR3. Although C. albicans CR3 and human CR3 cross-react and bind identical ligands, the two receptors differ in structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454341      PMCID: PMC281376          DOI: 10.1128/iai.61.4.1395-1399.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Candida albicans C3d receptor, isolated by using a monoclonal antibody.

Authors:  L Linehan; E Wadsworth; R Calderone
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

2.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.

Authors:  B J Gilmore; E M Retsinas; J S Lorenz; M K Hostetter
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Reduced expression of the functionally active complement receptor for iC3b but not for C3d on an avirulent mutant of Candida albicans.

Authors:  M W Ollert; E Wadsworth; R A Calderone
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Role of C3 in the control of monocyte C2 production.

Authors:  A O Hamilton; L Morrison; W S Kilpatrick; D Lappin; J C Bensa; D W Riches; K Whaley
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

6.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

7.  C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3.

Authors:  A Eigentler; T F Schulz; C Larcher; E M Breitwieser; B L Myones; A L Petzer; M P Dierich
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Third component of complement (C3): structural properties in relation to functions.

Authors:  V A Bokisch; M P Dierich; H J Mūller-Eberhard
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

9.  Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors.

Authors:  J E Edwards; T A Gaither; J J O'Shea; D Rotrosen; T J Lawley; S A Wright; M M Frank; I Green
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

10.  The mechanism of action of the C3b inactivator (conglutinogen-activating factor) on its naturally occurring substrate, the major fragment of the third component of complement (C3b).

Authors:  J D Gitlin; F S Rosen; P J Lachmann
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

View more
  23 in total

1.  Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18.

Authors:  Osama A Hamad; Ioannis Mitroulis; Karin Fromell; Huda Kozarcanin; Triantafyllos Chavakis; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Thromb Haemost       Date:  2015-08-13       Impact factor: 5.249

Review 2.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

3.  The effects of monoclonal antibodies against iC3b receptors in mice with experimentally induced disseminated candidiasis.

Authors:  K H Lee; M S Yoon; W H Chun
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

4.  Comparative study of the C3d receptor and 58-kilodalton fibrinogen-binding mannoproteins of Candida albicans.

Authors:  J L López-Ribot; J P Martínez; W L Chaffin
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

Review 5.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Complex interaction between different proteinaceous components within the cell-wall structure of Candida albicans.

Authors:  J L Lopez-Ribot; D A Cortlandt; D C Straus; K J Morrow; W L Chaffin
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

7.  Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles.

Authors:  Yvonne Klapper; Osama A Hamad; Yuji Teramura; Gero Leneweit; G Ulrich Nienhaus; Daniel Ricklin; John D Lambris; Kristina N Ekdahl; Bo Nilsson
Journal:  Biomaterials       Date:  2014-01-23       Impact factor: 12.479

8.  Analysis of mannoproteins from blastoconidia and hyphae of Candida albicans with a common epitope recognized by anti-complement receptor type 2 antibodies.

Authors:  E Wadsworth; S C Prasad; R Calderone
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

9.  Reduced inhibition of Candida albicans adhesion by saliva from patients receiving oral cancer therapy.

Authors:  M Umazume; E Ueta; T Osaki
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

10.  Binding of the extracellular matrix component entactin to Candida albicans.

Authors:  J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.